Introduction
Insomnia is often associated with long term benzodiazepine
(BZD) use. BZD use may result in additional adverse
outcomes, such as cognitive impairment, dementia, confusion
and balance difficulties that may lead to falls,
accidents and increased mortality [1–5]. The risks of tolerance,
dependence and abuse, and the efficacy and side
effects are quite similar for the three most common
benzodiazepines and benzodiazepine related drugs used
as hypnotics in Finland (temazepam, zopiclone and
zolpidem; here in short ‘BZD’) [1, 6–8]